Substituted oxadiazoles for combating phytopathogenic fungi

US10687532B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10687532-B2
Application numberUS-201615775429-A
CountryUS
Kind codeB2
Filing dateNov 14, 2016
Priority dateNov 13, 2015
Publication dateJun 23, 2020
Grant dateJun 23, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to novel oxadiazoles of the formula I, or the N-oxides and/or their agriculturally useful salts and to their use for controlling phytopathogenic fungi, or to a method for combating phytopathogenic harmful fungi, which process comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of the formula I, or an N-oxide, or an agriculturally acceptable salt thereof; the present invention also relates to agrochemical compositions comprising at least one such compound of the formula I and to agrochemical compositions further comprising seeds.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for combating phytopathogenic harmful fungi, which process comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of formula I: or an N-oxide or an agriculturally acceptable salt thereof; wherein: A is selected from the group consisting of subformulae (A.4), (A.5), and (A.8) wherein #1 denotes the position which is bound to the trifluoromethyloxadiazole moiety and #2 denotes the position which is connected to the NR 2 -L-Y-R 1 group and wherein the cyclic groups A are unsubstituted or substituted by 1, 2, 3 or 4 identical or different groups R A ; wherein R A is F, Cl, or Me L is selected from the group consisting of —C(═O)—, —C(═S)- and —S(═O) p ; p is 0, 1 or 2; Y is a bond or C 1 -C 4 -alkylene; wherein Y is unsubstituted or substituted by 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R Y ; R Y is selected from the group consisting of halogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio and C 3 -C 8 -cycloalkyl; R 1 is a 3- to 10-membered saturated, partially unsaturated, mono- or bicyclic carbocycle; or a 3- to 10-membered saturated, partially unsaturated, mono- or bicyclic heterocycle; and wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1, 2, 3 or 4 heteroatoms selected from the group consisting of N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from the group consisting of C(═O) and C(═S); and wherein any of the cyclic groups are unsubstituted or substituted by 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R 1a ; R 1a is selected from the group consisting of halogen, cyano, oxo, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -haloalkylthio, C 3 -C 8 -cycloalkyl, NHSO 2 -C 1 -C 4 -alkyl, —(C=O)-C 1 -C 4 -alkyl, C(═O)—C 1 -C 4 -alkoxy, C 1 -C 6 -alkylsulfonyl, hydroxyC 1 -C 4 -alkyl, C(═O)—NH 2 , C(═O)—NH(C 1 -C 4 -alkyl), C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, aminoC 1 -C 4 -alkyl, C 1 -C 4 -alkylamino-C 1 -C 4 -alkyl, diC 1 -C 4 -alkylamino-C 1 -C 4 -alkyl, aminocarbonyl-C 1 -C 4 -alkyl and C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl; R 2 is selected from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, ethynyl, propargyl, C 1 -C 6 -alkoxy, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkenyl, C(═O)-(C 1 -C 6 -alkyl) and C(═O)-(C 1 -C 6 -alkoxy); and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R 1a . 2. The method of claim 1 , wherein Y is a bond. 3. The method of claim 1 , wherein L is —C(═O)- or —S(═O) 2 -. 4. The method of claim 1 , wherein R 1 is C 3 -C 8 -cycloalkyl or C 3 -C 8 -cycloalkenyl and R 2 is selected from the group consisting of hydrogen, methyl, ethyl, allyl, ethynyl, propargyl and cyclopropyl; and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1, 2, 3 or up to the maximum possible number of identical or different groups R 1a as defined in claim 1 . 5. A compound of the formula I, or the N-oxides, or the agriculturally acceptable salts thereof wherein: A is selected from the group consisting of subformulae (A.4), (A.5), and (A.8) wherein #1 denotes the position which is bound to the trifluoromethyloxadiazole moiety and #2 denotes the position which is connected to the —NR 2 -L-Y-R 1 group and wherein the cyclic groups A are unsubstituted or substituted by 1 or 2 identical or different groups R A ; wherein R A is F, Cl, or Me L is selected from the group consisting of —C(═O)—, —C(═S)- and —S(═O) p ; p is 0, 1 or 2; Y is a bond or C 1 -C 4 -alkylene; wherein Y is unsubstituted or substituted by 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R Y ; R Y is selected from the group consisting of halogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio and C 3 -C 8 -cycloalkyl; R 1 is a 3- to 10-membered saturated, partially unsaturated, mono- or bicyclic heterocycle; and wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1, 2, 3 or 4 heteroatoms selected from the group consisting of N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from the group consisting of C(═O) and C(═S); and wherein the heterocycle is unsubstituted or substituted by 1, 2, 3,4 or up to the maximum possible number of identical or different groups R 1a ; R 1a is selected from the group consisting of halogen, cyano, oxo, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -haloalkylthio, C 3 -C 8 -cycloalkyl, NHSO 2 -C 1 -C 4 -alkyl, —(C=O)-C 1 -C 4 -alkyl, C(═O)—C 1 -C 4 -alkoxy, C 1 -C 6 -alkylsulfonyl, hydroxyC 1 -C 4 -alkyl, C(═O)—NH 2 , C(═O)—NH(C 1 -C 4 -alkyl), C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, aminoC 1 -C 4 -alkyl, C 1 -C 4 -alkylamino-C 1 -C 4 -alkyl, diC 1 -C 4 -alkylamino-C 1 -C 4 -alkyl, aminocarbonyl-C 1 -C 4 -alkyl and C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl; R 2 is selected from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, ethynyl, propargyl C 1 -C 6 -alkoxy, C 3 -C 8 -cycloalkyl, C 3 -C 8 -cycloalkenyl, C(═O)-(C 1 -C 6 -alkyl) and C(═O)-(C 1 -C 6 -alkoxy); and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R 1a ; with the exception of N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]-2,3,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3a-carboxamide. 6. The compound of claim 5 , wherein Y is a bond. 7. The compound of claim 5 , wherein L is —C(═O)-or —S(═O) 2 -. 8. The compound of claim 5 , wherein R 1 is C 3 -C 8 -cycloalkyl or C 3 -C 8 -cycloalkenyl and R 2 is selected from the group consisting of hydrogen, methyl, ethyl, allyl, ethynyl, propargyl, cyclopropyl and cyclobutyl; and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1, 2, 3, 4 or up to the maximum possible number of identical or different groups R 1a . 9. An agrochemical composition which comprises an auxiliary and at least one compound of the formula I or an N-oxide or an agriculturally acceptable salt thereof, according to claim 5 . 10. The agrochemical composition of claim 9 , wherein the auxiliary is selected from the group consisting of anionic, cationic and nonionic surfactants. 11. The agrochemical composition of claim 9 , further comprising a seed, wherein the amount of the compound of the formula I, or an N-oxide, or an agriculturally acceptable salt thereof, is from 0.1 g to 10 kg per 100 kg of seed.

Assignees

Inventors

Classifications

  • 1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles · CPC title

  • A01N43/82Primary

    five-membered rings with three ring hetero atoms · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10687532B2 cover?
The present invention relates to novel oxadiazoles of the formula I, or the N-oxides and/or their agriculturally useful salts and to their use for controlling phytopathogenic fungi, or to a method for combating phytopathogenic harmful fungi, which process comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack, with an effective amount of a…
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification A01N43/82. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).